2008
DOI: 10.1002/cncr.23938
|View full text |Cite
|
Sign up to set email alerts
|

Cancer screening and aging: Research barriers and opportunities

Abstract: Cancer is the second most common cause of death among those aged 65 years, and is a major cause of morbidity. There is some evidence that screening, by detecting precancerous lesions in asymptomatic patients, is effective in reducing cancer-related morbidity and mortality among older men and women. The objectives of the current review article were to identify some of the barriers to and opportunities for research in cancer screening among older individuals. Using expert opinion, the authors developed a taxonom… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
12
0
1

Year Published

2008
2008
2016
2016

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 16 publications
(13 citation statements)
references
References 93 publications
0
12
0
1
Order By: Relevance
“…1 Approximately 43% of men and 30% of women aged 65 years will develop cancer during their lifetime, 1 and cancer ranks as the second leading cause of death for older persons, after heart disease. 2 Based on the evidence supporting screening for colorectal cancer (CRC) 3,4 and breast cancer 4,5 , the US Preventive Services Task Force (USPSTF) recommends routine screening even at an older age (Appendix 1). 6 Hence, a mammography is recommended every 2 years for women 50 to 74 years of age.…”
Section: Introductionmentioning
confidence: 99%
“…1 Approximately 43% of men and 30% of women aged 65 years will develop cancer during their lifetime, 1 and cancer ranks as the second leading cause of death for older persons, after heart disease. 2 Based on the evidence supporting screening for colorectal cancer (CRC) 3,4 and breast cancer 4,5 , the US Preventive Services Task Force (USPSTF) recommends routine screening even at an older age (Appendix 1). 6 Hence, a mammography is recommended every 2 years for women 50 to 74 years of age.…”
Section: Introductionmentioning
confidence: 99%
“…Five studies were conducted in Europe: the United Kingdom (2), France (1), Switzerland (1), and Denmark (1); two in Australia (1) and New-Zealand (1), and one in two countries (U.S.A. and France). The articles were written in English (19) or French (1). Most used cross-sectional designs (19) and one used a longitudinal design (1).…”
Section: Resultsmentioning
confidence: 99%
“…13 There is also some controversy in the literature about this strict age cut-off because of the risk of not detecting aggressive prostate cancer in the men who are most likely to have it 17 and preventing men with more than 10 years of life expectancy from benefiting from screening. 18 Since primary care physicians (PCPs) play a critical role in screening uptake 19 , it is paramount to examine how PCPs decide to screen for prostate cancer in a context of such major scientific controversies and conflicting guidelines. Given that many guidelines point out the importance of informed decision making, it is also crucial to obtain better knowledge of the older patient's point of view.…”
Section: Introductionmentioning
confidence: 99%
“…Lebensjahr dar und werden wahrscheinlich die kardiovaskulären Erkrankungen als Todesursache Nummer 1 in wenigen Jahren übertreffen [13,17]. Ursache hierfür ist die deutlich zunehmende Inzidenz an Malignomen ab dem 6. und 7.…”
Section: Höhere Inzidenz Bösartiger Tumorenunclassified